Physician profile
Michael Cundiff
NPI 1871943167
$45,613.56
in general payments reported to CMS, 2019-2025
8 companies · $2,234 in 2025
The $2,234 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,750 · 2022: $15K · 2023: $22K · 2024: $3,480 · 2025: $2,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $16K · Travel and Lodging: $6,052 · Food and Beverage: $5,291 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,625.00 |
| Travel and Lodging | $6,051.86 |
| Food and Beverage | $5,290.72 |
| Education | $272.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,060.31 | 2022-2025 | Ensite Precision, Aveir, Ensite |
| Boston Scientific Corporation | $15,203.71 | 2021-2025 | Rhythmia Mapping System, Watchman Flx, Watchman Access System |
| Medtronic, INC. | $13,442.71 | 2022-2025 | Micra, Affera Mapping System, Selectsecure |
| Biosense Webster, INC. | $403.96 | 2024-2025 | Carto 3, Nuvision Ice Catheter |
| Biotronik INC. | $236.41 | 2023 | |
| Atricure, INC. | $221.39 | 2024-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Epi-Ease Epicardial Access System |
| Novo Nordisk INC | $28.07 | 2025 | Wegovy |
| Cordis US Corp. | $17.00 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cundiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.